Historical record - last NADAC publication: 6/22/2022

Product Information

QSYMIA 3.75 MG-23 MG CAPSULE is a brand product labeled by Vivus LLC, priced at $5.7651 per EA under NDC 62541020130. Its NADAC has been published 442 times since Dec 18, 2013.

QSYMIA 3.75 MG-23 MG CAPSULE

phentermine and topiramate

$5.7651per EA

DEA Schedule CIV

Strength

3.75; 23 mg/1; mg/1

Manufacturer

Vivus LLC

NDC

62541020130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/22/2022

Active Ingredients

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA022580

On Market Since

9/17/2012

Pharmacological Classes

Appetite Suppression

Cytochrome P450 2C19 Inhibitors

Cytochrome P450 3A4 Inducers

Decreased Central Nervous System Disorganized Electrical Activity

Increased Sympathetic Activity

Sympathomimetic Amine Anorectic

Price Statistics

The NADAC for QSYMIA 3.75 MG-23 MG CAPSULE has been published 442 times since Dec 18, 2013, and over the history we have for it it has risen 31.9%. The table below summarizes its recorded NADAC range and movement.

Current price	$5.7651 per EA
All-time high	$5.9301 (Apr 13, 2016)
All-time low	$4.3663 (Jan 22, 2014)
Median price	$5.7651
Average price	$5.6306
Largest weekly change	+11.0% (Apr 9, 2014)
Weeks tracked	442
Tracking since	Dec 18, 2013

Price History

0.0%

-0.2%

All

+31.9%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 43%

1 alternative • Same active ingredient

PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE

Generic

66993078030•Prasco Laboratories

$3.3050

Save 43%

Frequently asked questions

What is the NADAC price of QSYMIA 3.75 MG-23 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for QSYMIA 3.75 MG-23 MG CAPSULE, manufactured by Vivus LLC, is $5.7651 per EA (NDC 62541020130), effective Dec 28, 2022.

How has the price of QSYMIA 3.75 MG-23 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for QSYMIA 3.75 MG-23 MG CAPSULE has risen 31.9%. It has been tracked across 442 weekly CMS publications since Dec 18, 2013.

What are the highest and lowest recorded NADAC prices for QSYMIA 3.75 MG-23 MG CAPSULE?

Since Dec 18, 2013, the NADAC for QSYMIA 3.75 MG-23 MG CAPSULE has ranged from a low of $4.3663 (Jan 22, 2014) to a high of $5.9301 (Apr 13, 2016), with a median of $5.7651 per EA.

Are there cheaper alternatives to QSYMIA 3.75 MG-23 MG CAPSULE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE, is $3.3050 per EA — about 43% below QSYMIA 3.75 MG-23 MG CAPSULE.